Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03519581 · ClinicalTrials.gov registry record · NA
Micropulse for Suppression of Diabetic Macular Edema
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03519581 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 19 participants.
The verdict
NCT03519581, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Diabetic retinopathy is one of the most common complications of diabetes and diabetic macular edema (DME) is one of the most common causes of vision loss in diabetes. The purpose of this study is to determine if early intervention with micropulse laser treatment in eyes with good visual acuity (20/32 or better) will improve or stabilize vision loss due to the complications of diabetic macular edema.
Interventions
- DEVICE Sham Treatment
- DEVICE Micropulse Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-04-20 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03519581
The ClinicalTrials.gov registry entry for NCT03519581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT03519581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03519581 about?
NCT03519581 is a clinical study titled "Micropulse for Suppression of Diabetic Macular Edema". Diabetic retinopathy is one of the most common complications of diabetes and diabetic macular edema (DME) is one of the most common causes of vision loss in diabetes. The purpose of this study is to determine if early intervention with micropulse laser treatment in eyes with good visual acuity (20/...
What is the current status of trial NCT03519581?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-04-20. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03519581?
The interventions under investigation include: Sham Treatment (DEVICE), Micropulse Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT03519581?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.